Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    OpGen

    MCap

    USD15m

    Last close

    USD1.78

    ▲ 0.18 (11.13%)

    Substrate AI

    MCap

    EUR11m

    Last close

    EUR0.10

    ▲ 0.01 (11.11%)

    IRLAB Therapeutics

    MCap

    SEK679m

    Last close

    SEK13.10

    ▲ 1.00 (8.26%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Pharnext (PAR: ALPHA)

Last close As at 29/10/2024

EUR0.10

▲ 0.03 (42.86%)

Market capitalisation

1m

Edison Investment Research is terminating coverage on Pharnext (ALPHA). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Latest Insights

View More

Healthcare | Flash note

Pharnext — Potential licensing deals could add confidence

Healthcare | Update

Pharnext — Improving FY23 financial footing

Update

Pharnext — Revised legal structure to offer operational stability

Healthcare | Flash note

Pharnext — Neovacs trust to manage Pharnext deal
Visit Website

Sector

Healthcare

Balance Sheet

Forecast net debt (€m)

42.6

Forecast gearing ratio (%)

79

Share Price Performance

Price Performance
% 1M 3M 12M
Actual (87.2) (99) (99)
Relative (88) (99) (99)
52 week high/low €0.2/€0.0

Financials

Edison Investment Research is terminating coverage on ABC Arbitrage (ABCA), paragon (PGN), Foresight Solar Fund (FSFL), Kendrion (KENDR), Lithium Power International (LPI), Triple Point Energy Transition (TENT), 4iG (4IG), e-therapeutics (ETX), Pharnext (ALPHA) and Shield Therapeutics (STX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Y/E Dec Revenue (€m) EBITDA (€m) PBT (€m) EPS (fd) (c) P/E (x) P/CF (x)
2021A 3.6 (22.2) (30.6) (100.67) N/A N/A
2022A 2.3 (27.2) (38.5) (16.66) N/A N/A
2023E 1.9 (23.7) (24.7) (3579.47) N/A N/A
2024E 8.9 (10.8) (13.2) (1910.77) N/A N/A

Research

Update

Healthcare

Pharnext — Improving FY23 financial footing

Update

Pharnext — Revised legal structure to offer operational stability

Healthcare

Flash note

Pharnext — Potential licensing deals could add confidence
View All

Thematics

thematic

Healthcare

Outlook for 2024: Life sciences – where has the conviction gone?

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare
volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

thematic

Healthcare

ASCO 2023 key takeaways
View All

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free